The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Utility of the modified Glasgow Prognostic Score in patients with metastatic renal cell carcinoma treated with targeted agents.
Mikhail Y. Akbashev
No relevant relationships to disclose
Brian Michael Lingerfelt
No relevant relationships to disclose
Yuan Liu
No relevant relationships to disclose
Omer Kucuk
No relevant relationships to disclose
Viraj A. Master
No relevant relationships to disclose
Wayne Harris
No relevant relationships to disclose